ENTRY       D10776                      Drug
NAME        Obiltoxaximab (USAN/INN);
            Anthim (TN)
PRODUCT     ANTHIM (Elusys Therapeutics)
FORMULA     C6444H9994N1734O2022S44
EXACT_MASS  145430.0222
MOL_WEIGHT  145519.5678
SEQUENCE    (Heavy chain)
            QVQLQQSGPE LKKPGASVKV SCKDSGYAFS SSWMNWVRQA PGQGLEWIGR IYPGDGDTNY
            NGKFQGRVTI TADKSSSTAY MELSSLRSED TAVYFCARSG LLRYAMDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQDIR NYLNWYQQKP GKAVKLLIYY TSRLLPGVPS
            RFSGSGSGTD YSLTISSQEQ EDIGTYFCQQ GNTLPWTFGQ GTKVEIRRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
REMARK      ATC code: J06BC04
            Product: D10776<US>
EFFICACY    Anti-anthrax, Antitoxin
  DISEASE   Inhalational anthrax [DS:H00328]
  TYPE      Monoclonal antibody
COMMENT     Treatment of exposure to Bacillus anthracis spores
TARGET      protective antigen (PA) [KO:K11030]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BC Antibacterial monoclonal antibodies
                 J06BC04 Obiltoxaximab
                  D10776  Obiltoxaximab (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10776
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10776
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10776
DBLINKS     CAS: 1351337-07-9
            PubChem: 313046634
///
